KL

Kirti Lakshmikant Nitlikar

Active Director Director DIN 07469302
DIN 07469302 First appointment Apr 2016 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Kirti Lakshmikant Nitlikar

Data last updated:

Kirti Lakshmikant Nitlikar is a Director at Klops Life Sciences Private Limited (since 2016). The company operates in Chemicals.

DIN 07469302
Primary Designation Director
Industry Chemicals
First Appointment 26 Apr 2016
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Klops Life Sciences Private Limited U24290MH2016PTC280235
Director26 Apr 20162016Active

Directorship timeline

Open interactive timeline →
Klops Life Sciences Private Limited
Premium access

Shareholding and investment profile for Kirti Lakshmikant Nitlikar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kirti Lakshmikant Nitlikar

Kirti Lakshmikant Nitlikar currently holds 1 directorship: Klops Life Sciences Private Limited (Director, since 26 Apr 2016).

Kirti Lakshmikant Nitlikar was first appointed on 26 Apr 2016 as Director at Klops Life Sciences Private Limited.

The current boards of Kirti Lakshmikant Nitlikar's companies include Lakshmikant Hanumant Rao Nitlikar (Klops Life Sciences Private Limited), Pooja Santosh Chilgar (Klops Life Sciences Private Limited), Santosh Mahadev Chilgar (Klops Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available